GILEAD SCIENCES, INC.
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcellx Inc | 0 | 6,720,803 | +6,720,803 | 0 | 771,682,600 | — | +771,682,600 |
| Xilio Therapeutics Inc | 9,105,451 | 650,389 | -8,455,062 | 5,829,310 | 5,469,771 | — | -359,539 |
| Kyverna Therapeutics Inc | 4,126,119 | 4,126,119 | 0 | 38,785,519 | 35,608,407 | — | -3,177,112 |
| Assembly Biosciences Inc | 4,505,391 | 4,505,391 | 0 | 153,228,348 | 125,024,600 | — | -28,203,748 |
| Galapagos NV | 16,707,477 | 16,707,477 | 0 | 550,616,290 | 501,224,310 | — | -49,391,980 |
| Arcus Biosciences Inc | 31,424,760 | 31,424,760 | 0 | 748,852,031 | 678,774,816 | — | -70,077,215 |
| ARCELLX INC | 6,720,803 | 0 | -6,720,803 | 438,196,356 | 0 | — | -438,196,356 |